2-[3-(tert-butylcarbamoyl)phenyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 2-[3-(tert-butylcarbamoyl)phenyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid
• 英文别名: 2-[3-(tert-butylcarbamoyl)phenyl]-1,3-dioxoisoindole-5-carboxylic acid
• 化学式: C₂₀H₁₈N₂O₅
• mdl: MFCD01186275
• 分子量: 366.4
• InChiKey: NXMMGKCWIKUXOJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  27
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  104
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• Inhibitors of the S100-p53 protein-protein interaction and method of inhibiting cancer employing the same
  申请人：UNIVERSITY OF MARYLAND, BALTIMORE

  公开号：US20030219718A1

  公开（公告）日：2003-11-27

  Compounds that bind S100 and inhibit the S100-p53 protein-protein interaction and activate the tumor suppressor activity of p53, and thus which have an antineoplastic effect are disclosed, as well as methods for identifying these compounds, compositions comprising the same, and methods of using the same to treat cancer.

  本研究公开了结合 S100 并抑制 S100-p53 蛋白-蛋白相互作用和激活 p53 的肿瘤抑制活性从而具有抗肿瘤作用的化合物，以及鉴定这些化合物的方法、包含这些化合物的组合物和使用这些化合物治疗癌症的方法。
• INHIBITORS OF THE S100-p53 PROTEIN-PROTEIN INTERACTION AND METHOD OF INHIBITING CANCER EMPLOYING THE SAME
  申请人：THE UNIVERSITY OF MARYLAND AT BALTIMORE

  公开号：EP1539248A2

  公开（公告）日：2005-06-15
• EP1539248A4
  申请人：——

  公开号：EP1539248A4

  公开（公告）日：2007-12-26
• US8053477B2
  申请人：——

  公开号：US8053477B2

  公开（公告）日：2011-11-08
• [EN] INHIBITORS OF THE S100-p53 PROTEIN-PROTEIN INTERACTION AND METHOD OF INHIBITING CANCER EMPLOYING THE SAME<br/>[FR] INHIBITEURS DE L'INTERACTION PROTEINE-PROTEINE S100-P53 ET METHODE D'INHIBITION DU CANCER UTILISANT LESDITS INHIBITEURS
  申请人：UNIV MARYLAND

  公开号：WO2003084475A2

  公开（公告）日：2003-10-16

  Compounds that bind S100 and inhibit the S100-p53 protein-protein interaction and activate the tumor supressor activity of p53, and thus which have an antineoplastic effect are disclosed, as well as methods for identifying these compounds, compositions comprising the same, and methods of using the same to treat cancer.